The evolving role of Propionibacterium acnes in acne

Seminars in Cutaneous Medicine and Surgery

Volumn 20, Issue 3, 2001, Pages 139-143

  Leyden, J J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CEPHALOSPORIN DERIVATIVE; CHEMOTACTIC FACTOR; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; QUINOLONE DERIVATIVE; RETINOID; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ACNE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COUNT; BACTERIAL GROWTH; CORNEA CELL; DESQUAMATION; INFLAMMATION; PROPIONIBACTERIUM ACNES; REVIEW; SEBACEOUS GLAND; SEBUM; SKIN FLORA;

EID: 0034816621     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1053/sder.2001.28207     Document Type: Review

References (26)

1. Effect of tetracycline on the composition of sebum in acne vulgaris
2. Bacteriology
3. Propionibacterium levels in patients with and without acne vulgaris
4. Age-related changes in the resident bacterial flora of the human face
5. Regional variations of cutaneous propionibacteria
6. Regional variations of density of cutaneous propionibacteria: Correlation of P. acnes populations with sebaceous secretion
7. The relationship between bacteria and the abnormal keratinization in acne vulgaris
8. Modeling acne in-vitro
9. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by propionibacterium acnes
10. The chemoattractant properties of comedonal components
11. A histological and immunocytochemical study of early acne lesions
12. Immunohistochemical investigations of evolving inflammation in lesions of acne vulgaris
13. Polymorphonuclear leukocyte liposomal release in response to Propionibacterium acnes and its enhancement by sera from inflammatory acne patients
14. Complement activation in acne vulgaris: Consumption of complement by comedones
15. Presence of complement fixing antibodies to Corynebacterium acnes in the sera of patients with acne vulgaris
16. Complement activation in acne vulgaris: In vitro studies with Propionibacterium acnes and Propionibacterium granulosum
17. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne
18. The antimicrobial effect in vivo of minocycline, doxoycycline and tetracycline in humans
19. Tretinoin and antibiotic therapy in acne vulgaris
20. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erythromycin
21. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes
22. Propionibacterium acnes resistance to antibiotics in acne patients
23. Erythromycin-resistant propionibacteria in antibiotic-treated acne patients: Association with therapeutic failure
24. Multiple mechanisms of erythromycin resistance
25. Recalcitrant acne vulgaris: Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment
26. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia